sprite-preloader
Anzeige
Mehr »
Samstag, 21.10.2017 Börsentäglich über 12.000 News von 567 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrBoehringer Ingelheim partners with TARGET to progress NASH research
FrAlnylam, Vir to jointly advance RNAi therapeutics for infectious diseases
FrFDA approves Kite's Car T therapy Yescarta for B-Cell Lymphoma
DoTeva seeks FDA approval for migraine drug fremanezumab
MiTakeda, HemoShear collaborate to develop drugs for liver diseases
MiIgnyta's Entrectinib gets EMA prime designation for NTRK fusion-positive solid tumors
MiUS FDA accepts sBLA for Imfinzi in locally advanced and unresectable NSCLC
MiAmneal to acquire Impax to expand generics business in US
DiExelixis' liver cancer drug cabozantinib meets primary end point in phase 3 trial
DiPfizer's lung cancer drug lorlatinib succeeds in phase 2 trial
DiUS FDA accepts BMS' application for Opdivo (nivolumab) in patients with resected high-risk advanced melanoma
DiUS federal judge invalidates Allergan patents on Restasis
DimiRagen Therapeutics reports positive clinical data of MRG-106 in patients with mycosis fungoides form of cutaneous T-cell lymphoma
DiUK's NICE makes Nivolumab available for head and neck cancer patients
DiFDA panel backs approval of Aerie's Rhopressa for glaucoma treatment
13.10.Moleculin to collaborate with University of Bergen for immune stimulation drug
13.10.Human clinical trial commences for first leprosy vaccine candidate
13.10.FDA panel supports Spark Therapeutics gene therapy approval for rare form of blindness
12.10.Ardelyx's phase 3 study of Tenapanor for IBS-C meets primary endpoint
12.10.Janssen submits NDA to FDA for apalutamide to treat non-metastatic castration-resistant prostate cancer
12.10.Lupin buys Symbiomix to expand women's health specialty business
12.10.Sanofi to invest €170m for expansion of French vaccine manufacturing facility
11.10.Gilotrif gets FDA priority review for uncommon EGFR mutations in advanced NSCLC
11.10.Moffitt researchers discover new targets for approved cancer drug
11.10.Pfizer considers sale of consumer healthcare business